You have 9 free searches left this month | for more free features.

cutaneous T-cell lymphoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Cutaneous T Cell Lymphoma Trial in Chicago (APR-TD011 (RLF-TD011))

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • APR-TD011 (RLF-TD011)
  • Chicago, Illinois
    Dermatology CTU
Feb 6, 2023

Cutaneous T-cell Lymphoma Retreated With Brentuximab Vedotin

Not yet recruiting
  • T-Cell Lymphoma
  • No intervention
  • Bordeaux, France
  • +10 more
May 24, 2023

Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma

Recruiting
  • Lymphoma, T-cell, Peripheral
  • Lymphoma, T-cell, Cutaneous
  • Nagoya, Japan
  • +2 more
Nov 24, 2022

Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • +2 more
    • Ancona, Italy
    • +19 more
    Nov 2, 2023

    Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Fungoides Mycosis Sezary Syndrome
    • Ann Arbor, Michigan
      University of Michigan Comprehensive Cancer Center
    Jul 13, 2023

    T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

    Not yet recruiting
    • T-cell Lymphoma
    • +10 more
    • Chicago, Illinois
      Rush University Medical Center
    Oct 24, 2022

    Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)

    Recruiting
    • Advanced Solid Tumor
    • Cutaneous T-cell Lymphoma (CTCL)
    • Detroit, Michigan
    • +5 more
    Oct 6, 2022

    T-Cell Lymphoma Trial (Brentuximab vedotin)

    Not yet recruiting
    • T-Cell Lymphoma
    • Brentuximab vedotin
    • (no location specified)
    Jun 30, 2022

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • (no location specified)
    Dec 7, 2022

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin)

    Completed
    • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
    • Fairport, New York
      Rochester Skin Lymphoma Medical Group
    Aug 24, 2022

    Mycosis Fungoides Trial in Edmonton (Cemiplimab)

    Not yet recruiting
    • Mycosis Fungoides
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Sep 12, 2022

    Skin Barrier and Microbiome of CTCL Patients

    Not yet recruiting
    • Lymphoma, T-Cell, Cutaneous
      • Leiden, Netherlands
        Centre for Human Drug Research
      Apr 21, 2023

      Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))

      Recruiting
      • Cutaneous T Cell Lymphoma
      • Micro needle array-Doxorubicin (MNA-D)
      • Pittsburgh, Pennsylvania
        University Of Pittsburgh Medical Center
      Jun 2, 2022

      Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,

      Not yet recruiting
      • Mycosis Fungoides of Skin (Diagnosis)
      • +5 more
      • Med-Jet Injector
      • +4 more
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      Jan 17, 2023

      Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) Trial in Bordeaux, Paris (chlormethine gel)

      Recruiting
      • Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
      • chlormethine gel
      • Bordeaux, France
      • +1 more
      Aug 17, 2022

      Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid

      Active, not recruiting
      • Mycoses
      • +5 more
      • anti-thymocyte globulin
      • +2 more
      • Stanford, California
        Stanford University School of Medicine
      Jun 16, 2022

      Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Hypericin, Visible Light)

      Not yet recruiting
      • Cutaneous T Cell Lymphoma
      • Mycosis Fungoides
      • (no location specified)
      May 23, 2023

      Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

      Recruiting
      • Cutaneous T Cell Lymphoma
      • Peripheral T Cell Lymphoma
      • Microdevices
      • +2 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jul 16, 2022

      Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin, Mechlorethamine Topical Gel)

      Not yet recruiting
      • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
      • Fairport, New York
        Rochester Skin Lymphoma Medical Group
      Nov 20, 2023

      Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,

      Recruiting
      • Cutaneous T-Cell Lymphoma
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

      Recruiting
      • Folliculotropic Mycosis Fungoides
      • +7 more
      • Durvalumab
      • +2 more
      • Duarte, California
      • +3 more
      Jan 12, 2023

      Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in New York (UVADEX® (methoxsalen) Sterile Solution in conjunction with the

      Recruiting
      • Cutaneous T Cell Lymphoma
      • Mycosis Fungoides
      • UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis
      • THERAKOS® CELLEX photopheresis system
      • New York, New York
        Herbert Irving Pavilion
      Dec 23, 2022

      Tissue Repository: CTCL Collection Protocol

      Recruiting
      • Lymphoma, T-Cell, Cutaneous
      • +2 more
        • New York, New York
          Columbia University Medical Center
        May 2, 2022

        Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

        Active, not recruiting
        • Advanced Cancer
        • +16 more
        • Scottsdale, Arizona
        • +3 more
        Dec 22, 2022